Property, Plant, and Equipment: The sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Sangamo Therapeutics, Inc. (SGMO) had Property, Plant, and Equipment of $11.04M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$14.23M |
|
$-37.42M |
|
-- |
|
$14.23M |
|
$52.43M |
|
$-38.20M |
|
$0.23M |
|
$-37.97M |
|
$-37.97M |
|
$-37.42M |
|
$-37.42M |
|
$-37.42M |
|
$-37.42M |
|
$-38.20M |
|
$-36.32M |
|
280.19M |
|
280.19M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$35.83M |
|
|
Property, Plant, and Equipment |
$11.04M |
$23.91M |
|
$59.74M |
|
$42.47M |
|
-- |
|
$31.55M |
|
$74.01M |
|
$-14.27M |
|
$-14.27M |
|
$-14.27M |
|
350.69M |
|
| Cash Flow Statement Financials | |
$-97.21M |
|
$-0.10M |
|
$70.75M |
|
$43.42M |
|
$20.95M |
|
$-22.47M |
|
$9.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-268.51% |
|
-268.51% |
|
-- |
|
-266.88% |
|
-263.00% |
|
$-97.31M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
38.35 |
|
2.35 |
|
262.26% |
|
262.26% |
|
-62.63% |
|
262.26% |
|
$-0.04 |
|
$-0.35 |
|
$-0.35 |
|